Changes in asthma treatment improve wait time and patient care in emergency

Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics.

Asthma is the most common chronic illness in children requiring a visit to Emergency. Every year, the Children's Hospital of Eastern Ontario (CHEO) sees more than 2,500 with . Two thirds of these present with more than mild symptoms, meaning they have respiratory distress requiring increased levels of care, which may include requiring overnight admission to the hospital.

Traditionally, for patients presenting with asthma arriving at the Emergency Department (ED), the triage nursing staff would administer a relief medicine in a puffer or mask, to open the airways and ease breathing. Now, there is one more treatment option available on arrival in Emergency for children with moderate to severe asthma. This option empowers nurses to administer an oral .

are routinely used in the treatment of moderate to severe asthma. "Before this Medical Directive for asthma treatment was initiated at CHEO, patients and their families would have to wait to see a physician before the oral steroid could be ordered and given," said Debby Voskamp, nursing educator in CHEO's Emergency Department. "Because it often takes a few hours to see improvement in patients who receive oral steroid medication, it made sense to give this treatment early in the Emergency visit. We are pleased to be part of putting this research into practice and making positive change happen." The immediate impact on front line care has caught the eye of physicians, staff and hospital administrators alike.

CHEO's Emergency Department has 12 other Medical Directives in place now, but today's announcement is the first relating to administering steroids to treat asthma. This Medical Directive clearly documents the type of care children with asthma should receive, depending on how they score on a standardized assessment to determine the severity of their asthma performed by triage nurses when they arrive at the hospital. The assessment evaluates multiple factors including muscle exertion, wheezing and oxygen saturation.

"A critical part of this research included getting unanimous support from Pharmacy, Respirology, nursing educators and all of the Emergency physicians before we could implement the Medical Directive," said Dr. Roger Zemek. "We worked closely with the CHEO Medical Directive Committee and Medical Advisory Committee to prove that this Medical Directive is a safe, effective and appropriate intervention. We wanted to take asthma care to the next level, by offering rescue treatments over breathing treatments. Our strategy is something that other hospitals can model."

The front line impact of this research put into practice is significant. A review of more than 600 patients' medical records revealed that admission rates of patients with moderate to severe asthma dropped by one third, and patients who received oral steroids upon arrival at the tended to leave the hospital on average 45 minutes sooner. In fact, there was a direct correlation between how soon an oral steroid is administered and how soon patients gets better, as measured by their before and after scores on the standardized assessment.

Provided by Children's Hospital of Eastern Ontario Research Institute

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Nurse-initiated steroids improve pediatric asthma care

Mar 20, 2012

(HealthDay) -- Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, ...

Recommended for you

Ontario has one of the highest rates of IBD in the world

Aug 28, 2014

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at ...

New drug promises relief for inflammatory pain

Aug 27, 2014

Pain from inflammation sidelines thousands of Americans each year. Many face a tough choice: deal with the pain, take a potentially addictive opioid or use a nonsteroidal anti-inflammatory drug that may increase risk for ...

Overweight causes hazardous inflammations

Aug 25, 2014

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

Asthma outcomes worse in older women

Aug 21, 2014

(HealthDay)—Older women face increased challenges in managing their asthma, according to a review published in the August issue of the Annals of Allergy, Asthma & Immunology.

User comments